Sarda Proteins Ltd (BOM:519242)
India
· Delayed Price · Currency is INR 84.48
0.00 (0.00%)
At close: Apr 27, 2026
Sarda Proteins Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Operating Revenue | 155.08 | 241.91 | 12.96 | 57.95 | 107.6 | 113.6 | Upgrade
|
| Other Revenue | 0 | 0 | - | - | - | -0 | Upgrade
|
| Revenue | 155.09 | 241.91 | 12.96 | 57.95 | 107.6 | 113.6 | Upgrade
|
| Revenue Growth (YoY) | -36.05% | 1766.88% | -77.64% | -46.14% | -5.28% | 110.35% | Upgrade
|
| Cost of Revenue | 154.78 | 239.11 | 12.07 | 57.18 | 102.86 | 109.81 | Upgrade
|
| Gross Profit | 0.31 | 2.8 | 0.89 | 0.77 | 4.73 | 3.79 | Upgrade
|
| Selling, General & Admin | 0.59 | 1 | 1.59 | 1.48 | 1.39 | 1.34 | Upgrade
|
| Other Operating Expenses | 3.84 | 1.61 | 0.76 | 0.77 | 0.64 | 2.66 | Upgrade
|
| Operating Expenses | 4.44 | 2.61 | 2.35 | 2.24 | 2.03 | 4.01 | Upgrade
|
| Operating Income | -4.14 | 0.2 | -1.46 | -1.47 | 2.7 | -0.21 | Upgrade
|
| Interest Expense | - | - | -0 | - | -0 | -0.01 | Upgrade
|
| Interest & Investment Income | 0.01 | 0.01 | 1.65 | 1.6 | 0.85 | 0.84 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.05 | 0 | 0 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -3.09 | 0.2 | 0.19 | 0.13 | 3.55 | 0.61 | Upgrade
|
| Other Unusual Items | - | - | - | - | -0.02 | - | Upgrade
|
| Pretax Income | -3.09 | 0.2 | 0.19 | 0.13 | 3.53 | 0.61 | Upgrade
|
| Income Tax Expense | 0.15 | 0.15 | -0.01 | 0.46 | 0.45 | 0.82 | Upgrade
|
| Net Income | -3.24 | 0.05 | 0.19 | -0.33 | 3.07 | -0.2 | Upgrade
|
| Net Income to Common | -3.24 | 0.05 | 0.19 | -0.33 | 3.07 | -0.2 | Upgrade
|
| Net Income Growth | - | -73.71% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 2 | 2 | 2 | 2 | 2 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 2 | 2 | 2 | 2 | 2 | 2 | Upgrade
|
| Shares Change (YoY) | 0.73% | - | - | - | - | - | Upgrade
|
| EPS (Basic) | -1.87 | 0.03 | 0.11 | -0.19 | 1.78 | -0.12 | Upgrade
|
| EPS (Diluted) | -1.87 | 0.03 | 0.11 | -0.19 | 1.78 | -0.12 | Upgrade
|
| EPS Growth | - | -73.14% | - | - | - | - | Upgrade
|
| Free Cash Flow | - | -1.11 | -2.31 | -3.01 | 1.04 | -0.51 | Upgrade
|
| Free Cash Flow Per Share | - | -0.64 | -1.34 | -1.75 | 0.60 | -0.29 | Upgrade
|
| Gross Margin | 0.20% | 1.16% | 6.84% | 1.34% | 4.40% | 3.34% | Upgrade
|
| Operating Margin | -2.67% | 0.08% | -11.30% | -2.54% | 2.51% | -0.19% | Upgrade
|
| Profit Margin | -2.09% | 0.02% | 1.50% | -0.57% | 2.86% | -0.18% | Upgrade
|
| Free Cash Flow Margin | - | -0.46% | -17.82% | -5.20% | 0.97% | -0.45% | Upgrade
|
| EBITDA | - | - | - | -1.46 | 2.7 | -0.21 | Upgrade
|
| EBITDA Margin | - | - | - | -2.53% | 2.51% | -0.18% | Upgrade
|
| D&A For EBITDA | - | - | - | 0 | 0 | 0 | Upgrade
|
| EBIT | -4.14 | 0.2 | -1.46 | -1.47 | 2.7 | -0.21 | Upgrade
|
| EBIT Margin | -2.67% | 0.08% | -11.30% | -2.53% | 2.51% | -0.19% | Upgrade
|
| Effective Tax Rate | - | 74.75% | - | 355.43% | 12.86% | 133.10% | Upgrade
|
| Revenue as Reported | 156.14 | 241.92 | 14.61 | 59.55 | 108.45 | 114.44 | Upgrade
|
| Advertising Expenses | - | 0.06 | 0.07 | 0.07 | 0.07 | 0.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.